CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 28, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net cash provided by operating activities	$ 610,203	$ 496,232
Cash flows from investing activities:
Capital expenditures	(67,026)	(83,229)
Origination of finance receivables	(1,869,569)	(2,064,899)
Collections on finance receivables	1,785,698	1,768,829
Sales and redemptions of marketable securities	0	10,007
Acquisition of business	0	(7,000)
Other investing activities	(381)	11,717
Net cash used by investing activities	(151,278)	(364,575)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	1,396,602	546,655
Repayments of medium-term notes	(1,400,000)	(750,000)
Proceeds from securitization debt	2,064,450	1,021,353
Repayments of securitization debt	(369,613)	(113,806)
Borrowings of asset-backed commercial paper	225,187	23,373
Repayments of asset-backed commercial paper	(143,306)	(155,286)
Net increase in unsecured commercial paper	831,354	(728,606)
Net increase in credit facilities	150,000	0
Deposits	17,995	0
Dividends paid	(61,917)	(120,841)
Repurchase of common stock	(7,156)	(104,621)
Issuance of common stock under share-based plans	41	833
Net cash provided (used) by financing activities	2,703,637	(380,946)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(382)	3,439
Net increase (decrease) in cash, cash equivalents and restricted cash	3,162,180	(245,850)
Cash, cash equivalents and restricted cash, beginning of period	905,366	1,259,748
Net increase (decrease) in cash, cash equivalents and restricted cash	3,162,180	(245,850)
Cash, cash equivalents and restricted cash, end of period	4,067,546	1,013,898
Reconciliation of cash, cash equivalents and restricted cash on the Consolidated balance sheets to the Consolidated statements of cash flows:
Cash and cash equivalents	3,856,597	924,638
Restricted cash	189,712	82,248
Restricted cash included in Other long-term assets	$ 21,237	$ 7,012